Stericycle’s (SRCL) Buy Rating Reaffirmed at Stifel Nicolaus
Stifel Nicolaus reaffirmed their buy rating on shares of Stericycle, Inc. (NASDAQ:SRCL) in a report issued on Thursday, Marketbeat.com reports. The firm currently has a $85.00 price target on the business services provider’s stock, down from their prior price target of $95.00.
A number of other equities research analysts have also issued reports on SRCL. Jefferies Group LLC reiterated a buy rating and issued a $108.00 target price on shares of Stericycle in a research note on Thursday, July 13th. BidaskClub upgraded Stericycle from a strong sell rating to a sell rating in a research note on Monday, July 24th. Zacks Investment Research lowered Stericycle from a buy rating to a hold rating in a research note on Monday, August 7th. Barclays PLC reiterated an overweight rating and issued a $100.00 target price on shares of Stericycle in a research note on Wednesday, August 9th. Finally, William Blair reiterated an ourperform rating on shares of Stericycle in a research note on Thursday, September 14th. Four equities research analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. Stericycle currently has an average rating of Hold and an average price target of $77.17.
Shares of Stericycle (NASDAQ SRCL) traded down $0.04 during trading hours on Thursday, reaching $64.02. The company’s stock had a trading volume of 1,738,000 shares, compared to its average volume of 818,549. The firm has a market capitalization of $5,470.00, a price-to-earnings ratio of 14.75, a PEG ratio of 1.75 and a beta of 0.19. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82. Stericycle has a 12 month low of $61.62 and a 12 month high of $88.00.
Stericycle (NASDAQ:SRCL) last posted its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.04). Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The company had revenue of $883.00 million during the quarter, compared to analyst estimates of $896.81 million. During the same quarter last year, the business posted $1.24 EPS. Stericycle’s quarterly revenue was down .8% compared to the same quarter last year. research analysts predict that Stericycle will post 4.49 EPS for the current year.
TRADEMARK VIOLATION WARNING: “Stericycle’s (SRCL) Buy Rating Reaffirmed at Stifel Nicolaus” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/13/stericycles-srcl-buy-rating-reaffirmed-at-stifel-nicolaus.html.
In other Stericycle news, Director Mark C. Miller sold 19,753 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $70.52, for a total transaction of $1,392,981.56. Following the completion of the sale, the director now owns 205,576 shares in the company, valued at approximately $14,497,219.52. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 3.30% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of SRCL. Schroder Investment Management Group acquired a new stake in Stericycle during the 2nd quarter valued at approximately $80,497,000. Thompson Siegel & Walmsley LLC acquired a new stake in Stericycle during the 2nd quarter valued at approximately $33,710,000. Strs Ohio grew its stake in Stericycle by 26,943.3% during the 2nd quarter. Strs Ohio now owns 328,306 shares of the business services provider’s stock valued at $25,056,000 after purchasing an additional 327,092 shares in the last quarter. BlackRock Inc. grew its stake in Stericycle by 6.4% during the 2nd quarter. BlackRock Inc. now owns 5,413,244 shares of the business services provider’s stock valued at $413,139,000 after purchasing an additional 323,664 shares in the last quarter. Finally, Clarkston Capital Partners LLC lifted its holdings in Stericycle by 43.1% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,013,885 shares of the business services provider’s stock worth $72,614,000 after buying an additional 305,441 shares during the last quarter. Hedge funds and other institutional investors own 94.19% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.